Skip to main content

Day: September 15, 2020

LPL Financial Advisors Ranked Among Top 100 Independent Advisors Nationwide

CHARLOTTE, N.C., Sept. 15, 2020 (GLOBE NEWSWIRE) — LPL Financial LLC (Nasdaq:LPLA), a leading retail investment advisory firm, independent broker-dealer and registered investment advisor (RIA) custodian, today announced that four of its affiliated advisors have been ranked on the 2020 list of the Top 100 Independent Financial Advisors in America published in Barron’s.The annual list highlights the nation’s top 100 independent financial advisors based on data including assets under management, revenue generated for the firm and the overall quality of the advisor’s practice. LPL advisors recognized on this year’s list include:Susan Kaplan, Kaplan Financial Services, Newton, Mass.Laila Pence, Pence Wealth Management, Newport Beach, Calif.Andy Schwartz, Bleakley Financial Group, Fairfield, N.J.Charles Zhang, Zhang Financial, Portage,...

Continue reading

10x Genomics Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

PLEASANTON, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (NASDAQ: TXG) (the “Company”) today announced the closing of its public offering of 4,600,000 shares of its Class A common stock, which included the exercise in full of the underwriters’ option to purchase 600,000 additional shares of its Class A common stock, at a public offering price of $110.00 per share. Including the option exercise, the aggregate gross proceeds from the offering were $506 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. All of the shares were offered by the Company.J.P. Morgan Securities LLC, BofA Securities and Cowen and Company, LLC acted as lead joint book-running managers for the offering.  Stifel and William Blair acted as co-managers for the offering.Registration...

Continue reading

Apex Global Brands Reports Second Quarter 2021 Financial Results

Second Quarter Fiscal 2021 Highlights versus Second Quarter Fiscal 2020: Revenues declined to $4.4 million from $5.6 millionAdjusted EBITDA decreased to $2.3 million from $2.5 millionNet loss of $1.3 was in-line with the previous period  SG&A expenses declined significantly to $2.1 million from $3.1 millionEffected a 1-for-10 reverse stock splitEntered into an amended forbearance agreement with senior secured lender on September 1, 2020, including the suspension of interest and principal payments through December 31, 2020Accelerated Maturity Date on all senior debt from August 3, 2021 to March 31, 2021Received notification from Nasdaq that Apex was no longer in compliance with the minimum publicly held share count requirementSHERMAN OAKS, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) — Apex Global Brands (Nasdaq: APEX), a global...

Continue reading

La-Z-Boy Completes Seattle-Market Acquisition

MONROE, Mich., Sept. 15, 2020 (GLOBE NEWSWIRE) — La-Z-Boy Incorporated (NYSE: LZB), a global leader in residential furniture, today announced the completion of its previously announced asset acquisition of the Seattle, Washington business that operated six independently owned La-Z-Boy Furniture Galleries® stores, with approximately $30 million in annual retail volume in calendar 2019, and one warehouse. The transaction is the result of the planned retirement of independent dealers, Chris and Lisa Washko. The stores have become part of La-Z-Boy’s Retail segment, which is now composed of 159 stores.Kurt L. Darrow, Chairman, President and Chief Executive Officer of La-Z-Boy, said, “We are thrilled to have acquired the strong base of La-Z-Boy Furniture Galleries® stores in the Seattle market. The stores have historically performed...

Continue reading

Enzon Pharmaceuticals Announces Key Dates for Rights Offering

CRANFORD, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) — Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) announced today the record date and expected subscription period for its previously-announced rights offering to raise proceeds of approximately $43 million.  The proceeds from the rights offering will be utilized to position the Company as a public company acquisition vehicle, where it can become an acquisition platform and more fully utilize its net operating loss tax carryforwards and enhance stockholder value.The Company filed Amendment Number 1 to its Registration Statement on Form S-1 providing 5:00 p.m., New York City time, on September 23, 2020 as the record date.  Subject to the Registration Statement becoming effective on or about September 18, 2020, the Company intends to commence the rights offering on...

Continue reading

Kelly® to Participate in Sidoti Fall 2020 Virtual Investor Conference

TROY, Mich., Sept. 15, 2020 (GLOBE NEWSWIRE) — Kelly (Nasdaq: KELYA) (Nasdaq: KELYB), a leading specialty talent solutions provider, today announced it will be presenting at the Sidoti Fall 2020 Virtual Investor Conference that is to be held on September 23 & 24, 2020.In addition to participating in virtual one-on-one meetings, Peter Quigley, president and CEO, Olivier Thirot, executive vice president and chief financial officer, and James Polehna, senior vice president and corporate secretary, will review the company’s strategy and performance. The presentation can be accessed at kellyservices.com and will begin at 2:30 p.m. ET on Thursday, September 24, 2020. An audio replay of the presentation will be available on the Company’s website following the live presentation as well.About Kelly®Kelly Services, Inc. (Nasdaq: KELYA,...

Continue reading

PRA Health Sciences Announces Appointment of New Director

RALEIGH, N.C., Sept. 15, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ:PRAH) today announced the appointment of Glen Stettin, M.D. to the Board of Directors of the Company, effective September 14, 2020.“We are delighted that Glen will be joining our Board of Directors.  With his widespread involvement in the healthcare field as both a physician and an executive, Dr. Stettin’s experience in innovation, data, analytics, technology and integrated health solutions will provide the Board with valuable insight as we continue to reinvent clinical research and make it more accessible to patients,” said Colin Shannon, President, Chief Executive Officer and Chairman of the Board of Directors of PRA Health Sciences, Inc.Dr. Stettin is Senior Vice President and Chief Innovation Officer at Express Scripts & Cigna Services, a...

Continue reading

Teradyne Announces Senior Management Changes

NORTH READING, Mass., Sept. 15, 2020 (GLOBE NEWSWIRE) — Teradyne, Inc. (Nasdaq: TER) today announced two senior management changes. Gregory Smith has been appointed to the newly created position of President of Teradyne’s Industrial Automation Group, while Richard Burns has been appointed President of Teradyne’s Semiconductor Test Division, replacing Mr. Smith. Both appointments are effective October 1, 2020.“Greg and Rick have been key drivers of our Semiconductor Test team’s market and business success,” said Teradyne President and CEO Mark Jagiela. “In his new role, Greg will lead our expanding Industrial Automation Group, including Universal Robots, MiR and AutoGuide. These platforms are technology leaders with strong management teams in place and Greg’s experience developing and growing high-performing teams, while expanding...

Continue reading

Monolithic Power Systems Announces Third Quarter Dividend

KIRKLAND, Wash., Sept. 15, 2020 (GLOBE NEWSWIRE) — Monolithic Power Systems (MPS) (Nasdaq: MPWR), a leading company in high-performance analog solutions, today announced its third quarter dividend of $0.50 per common share to all stockholders of record as of the close of business on September 30, 2020. The dividend will be paid to stockholders on October 15, 2020.Safe Harbor StatementThis news release includes “forward-looking statements” intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on our current expectations, estimates and projections about our business and industry, management’s beliefs, and certain assumptions made by us, all of which are subject to change. Forward-looking statements can often be identified...

Continue reading

Voyager Therapeutics Appoints Nancy Vitale to its Board of Directors

CAMBRIDGE, Mass., Sept. 15, 2020 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today announced the addition of Nancy Vitale as an independent director to its Board of Directors, effective as of September 15, 2020. Ms. Vitale brings more than 25 years of experience to Voyager’s Board, with deep expertise in human resources. She is a former Senior Vice President and Chief Human Resource Officer at Genentech, a member of the Roche Group.“We are thrilled to welcome Nancy to our Board,” said Andre Turenne, President and CEO of Voyager. “Nancy’s accomplished background in helping organizations thrive by focusing on a strong patient-centric culture and employee wellbeing will be enormously valuable as we...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.